Development of Optofluidic Resonators for Filoviral Detection
Project Number5K08EB033409-04
Former Number1K08EB033409-01
Contact PI/Project LeaderQAVI, ABRAHAM JALEEL
Awardee OrganizationUNIVERSITY OF CALIFORNIA-IRVINE
Description
Abstract Text
Project Summary/Abstract
This proposal describes a 4-year career development plan for the PI, Dr. Abraham J. Qavi, MD, PhD, with the
goal of preparing him for an independent research career as a physician scientist. This plan includes expand
training opportunities and a pathway to an independent career that includes the development and implementation
of sensor technologies and its application towards filoviruses, namely Ebola. The PI graduated with degrees in
Biochemistry & Molecular Biology and Chemistry from the University of California, Irvine. He then enrolled in the
Medical Scholars Program at the University of Illinois at Urbana-Champaign, where he earned his MD and PhD
in Chemistry. Dr. Qavi continued his medical training as part of the Clinical Pathology Physician Scientist Training
Program at Washington University in St. Louis and the Barnes-Jewish Hospital consortium. During his residency
elective time, he began research in the laboratory of Dr. Lan Yang, who will serve as his co-mentor together with
Dr. Amarasinghe. Dr. Yang is the Edwin H. and Florence G. Skinner Professor of Electrical & Systems
Engineering, and an internationally renowned researcher in photonics. In 2019, Dr. Qavi added an additional
training component under the co-mentorship with Dr. Gaya Amarasinghe, Professor of Pathology & Immunology,
to expand the application of his previously developed sensor technology to infectious disease reach.
The goal of this study is the development of a rapid, multiplexed optofluidic sensor platform for
the rapid detection of pathogens, with an initial focus on Ebola. Filoviruses, such as Ebola, are among the
most lethal human pathogens, with high case fatality rates during outbreaks. Critical in the identification and
management of outbreaks are robust detection methods that can be implemented rapidly and sensitively. To
address this critical need, Whispering Gallery Mode (WGM) sensors will be leveraged. WGM devices are a class
of optical sensors in which light is confined within a micron-scale volume. These devices have incredibly high
sensitivity, small sensor footprint, ease of integration with conventional electronics, and low fabrication costs.
Microbubble resonators (MBRs), a subclass of WGM sensors, offer the advantages of conventional WGM
devices while enabling coupling of optical and the fluidic components into a single component. The goal of this
proposal is the use of an optofluidic sensor platform based on MBRs for the rapid, multiplexed detection of Ebola.
The workflow and advancements, including MBR development, engineered antibodies, biophysical validation
and multiplexing, will provide the framework to extend the work beyond the initial goals and promote facile
transition to an independent career for Dr. Qavi.
Public Health Relevance Statement
Project Narrative
Increased infectious disease outbreaks, highlighted by the current COVID-19 pandemic, serves as a constant
reminder of the importance of diagnostics for infectious diseases and the large diagnostic gap in our response
arsenal. Whispering Gallery Mode (WGM) devices that consist of microbubble resonators are a novel class of
highly sensitive optical sensor with simple fluid handling. Through these studies, we will address this gap and
leverage microbubble resonators for the rapid, multiplexed detection of viruses as a versatile biosensing
platform both for laboratory and field deployment.
NIH Spending Category
No NIH Spending Category available.
Project Terms
2019-nCoVAddressAffinityAfricaAfrica South of the SaharaAreaBindingBiochemistryBiological AssayBiophysicsBiosensing TechniquesBuffersCOVID-19 pandemicCaliforniaCase Fatality RatesCessation of lifeChemistryClinical PathologyCold ChainsCommunicable DiseasesComplexCouplingDataDemocratic Republic of the CongoDetectionDevelopmentDevelopment PlansDevicesDiagnosticDiseaseDisease OutbreaksDoctor of PhilosophyEbolaEbola Hemorrhagic FeverEbola virusElectronicsEngineeringEnrollmentEnzyme-Linked Immunosorbent AssayFilovirusFoundationsGlycoproteinsGoalsHospitalsIllinoisImmune responseImmunologyIndividualInfectionInternationalLaboratoriesLasersLassa virusLeadLightLiquid substanceMeasurementMedicalMentorsMentorshipMethodsMicrobubblesMolecular BiologyMonoclonal AntibodiesOpticsOutputPathogen detectionPathogenicityPathologyPathway interactionsPerformancePhasePhysiciansPositioning AttributeProcessProtein BiochemistryProtein EngineeringRNA VirusesReagentReporterResearchResearch PersonnelResidenciesSamplingScholars ProgramScientistSentinelSerologySignal TransductionSourceSystemTechniquesTestingTimeTrainingUniversitiesValidationVesicular stomatitis Indiana virusViralViral GenomeViral Hemorrhagic FeversViral MarkersViral ProteinsVirusVirus DiseasesWashingtonWorkanalytical toolantibody engineeringantibody mimeticscareercareer developmentdesigndetection methoddiagnostic assaydiagnostic developmentemerging pathogenemerging virusfollower of religion Jewishhuman pathogenmanufacturing costmultiplex detectionnanoparticlenew outbreaknovelnovel diagnosticsoptical sensorparticlepathogenphotonicsphysician-scientist training programprofessorprogramsrapid detectionresponsesensorsensor technologystandard of caretraining opportunityviral detectionvirology
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
046705849
UEI
MJC5FCYQTPE6
Project Start Date
01-August-2022
Project End Date
31-May-2026
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$189,713
Direct Costs
$175,660
Indirect Costs
$14,053
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$189,713
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08EB033409-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08EB033409-04
Patents
No Patents information available for 5K08EB033409-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08EB033409-04
Clinical Studies
No Clinical Studies information available for 5K08EB033409-04
News and More
Related News Releases
No news release information available for 5K08EB033409-04
History
No Historical information available for 5K08EB033409-04
Similar Projects
No Similar Projects information available for 5K08EB033409-04